Group 1 - The company Zhejiang Zhenyuan announced on September 24 that the funds from the private placement will primarily be used for synthetic biology projects and the construction of raw material drug aggregation enhancement projects [2] - Currently, the synthetic biology project S1 production line has been put into operation [2]